New heart monitor technology detects cardiac issues fox17online.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fox17online.com Daily Mail and Mail on Sunday newspapers.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Global Cardiovascular Digital Solutions Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. Business strategies of the key players and the new entering market industries are studied in detail. Well explained SWOT analysis, revenue share and contact information are shared in this report analysis.
Top Key Players Profiled in this report are:
Hillrom Comments on Recent Novitas Reimbursement Update
News provided by
Share this article
Share this article
CHICAGO, April 11, 2021 /PRNewswire/ Hillrom (NYSE: HRC) previously announced its intent to acquire Bardy Diagnostics, Inc. (BardyDx). On April 10, 2021, the Medicare Administrative Contractor (MAC), Novitas Solutions, published updated reimbursement rates applicable to the Current Procedural Terminology (CPT) codes 93241, 93243, 93245 and 93247 for the extended Holter cardiac monitoring category applicable to all of BardyDx s products and services. The original Novitas rate decision was published on January 29, 2021.
Following the updated Novitas rate decision, Hillrom reconfirms its position that a Company Material Adverse Effect has occurred under the acquisition agreement with BardyDx, and therefore closing conditions have not been satisfied. Hillrom will not comment further due to current litigation with BardyDx, which is pending in the Delaware Court of Chance
CHICAGO, April 11, 2021 /PRNewswire/ Hillrom previously announced its intent to acquire Bardy Diagnostics, Inc. . On April 10, 2021, the Medicare Administrative Contractor , Novitas Solutions,. | April 11, 2021
First published on
While attention focused on iRhythm Technologies after Medicare rates for long-term cardiac monitoring were slashed in January, the fallout is now extending to other players and the future of the much-hyped market is being questioned.
Novitas Solutions, which sets regional Medicare rates as a Medicare Administrative Contractor, is working with iRhythm and rivals about possibly changing the published rates. However, there is no timetable for when or if the rates will change, leaving Wall Street and industry in a holding pattern.
Baird Equity Research analyst Mike Polark said that the reimbursement uncertainty makes any long-term growth expectation for iRhythm and the overall cardiac wearables market difficult.